Do we need a pharmacist in the ICU?

被引：23

作者：

Chant, Clarence ^{[1
,2
]}

Dewhurst, Norman F. ^{[1
]}

Friedrich, Jan O. ^{[2
,3
]}

机构：

[1] St Michaels Hosp, Dept Pharm, Toronto, ON M5B 1W8, Canada

[2] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada

[3] St Michaels Hosp, Crit Care Dept, Toronto, ON M5B 1W8, Canada

来源：

INTENSIVE CARE MEDICINE | 2015年 / 41卷 / 07期

关键词：

INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; CLINICAL PHARMACIST; HOSPITAL PHARMACIST; ECONOMIC OUTCOMES; IMPACT; PARTICIPATION; SERVICES; EVENTS; COST;

D O I：

10.1007/s00134-015-3718-0

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1314 / 1320

页数：7

共 19 条

[1] Impact of clinical pharmacist on cost of drug therapy in the ICU [J].

Aljbouri, Tareq M. ;

Alkhawaldeh, Mohammed S. ;

Abu-Rumman, Ala'a Eddeen K. ;

Hasan, Thamer A. ;

Khattar, Hakeem M. ;

Abu-Oliem, Atallah S. .

SAUDI PHARMACEUTICAL JOURNAL, 2013, 21 (04) :371-374

[2] Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model [J].

Brilli, RJ ;

Spevetz, A ;

Branson, RD ;

Campbell, GM ;

Cohen, H ;

Dasta, JF ;

Harvey, MA ;

Kelley, MA ;

Kelly, KM ;

Rudis, MI ;

St Andre, AC ;

Stone, JR ;

Teres, D ;

Weled, BJ .

CRITICAL CARE MEDICINE, 2001, 29 (10) :2007-2019

[3] The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost [J].

Devlin, JW ;

Holbrook, AM ;

Fuller, HD .

ANNALS OF PHARMACOTHERAPY, 1997, 31 (06) :689-695

[4] Interdisciplinary Patient Care in the Intensive Care Unit: Focus on the Pharmacist [J].

Erstad, Brian L. ;

Haas, Curtis E. ;

O'Keeffe, Terence ;

Hokula, Cheryl A. ;

Parrinello, Kathleen ;

Theodorou, Andreas A. .

PHARMACOTHERAPY, 2011, 31 (02) :128-137

[5] Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit [J].

Jiang, Sai-Ping ;

Zhu, Zheng-Yi ;

Ma, Kui-Fen ;

Zheng, Xia ;

Lu, Xiao-Yang .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (12) :891-899

[6]

Jiang SP, 2012, SAUDI MED J, V33, P756

[7] On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study [J].

Klopotowska, Joanna E. ;

Kuiper, Rob ;

van Kan, Hendrikus J. ;

de Pont, Anne-Cornelie ;

Dijkgraaf, Marcel G. ;

Lie-A-Huen, Loraine ;

Vroom, Margreeth B. ;

Smorenburg, Susanne M. .

CRITICAL CARE, 2010, 14 (05)

[8] Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist [J].

Kopp, Brian J. ;

Mrsan, Melinda ;

Erstad, Brian L. ;

Duby, Jeremiah J. .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (23) :2483-2487

[9] Pharmacist participation on physician rounds and adverse drug events in the intensive care unit [J].

Leape, LL ;

Cullen, DJ ;

Clapp, MD ;

Burdick, E ;

Demonaco, HJ ;

Erickson, JI ;

Bates, DW .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03) :267-270

[10] International critical care hospital pharmacist activities [J].

LeBlanc, Jaclyn M. ;

Seoane-Vazquez, Enrique C. ;

Arbo, Trudy C. ;

Dasta, Joseph F. .

INTENSIVE CARE MEDICINE, 2008, 34 (03) :538-542

← 1 2 →